CUTR vs. FONR, TTOO, NSPR, VANI, PDEX, BLAC, SEPA, SURG, STIM, and CTSO
Should you be buying Cutera stock or one of its competitors? The main competitors of Cutera include FONAR (FONR), T2 Biosystems (TTOO), InspireMD (NSPR), Vivani Medical (VANI), Pro-Dex (PDEX), Bellevue Life Sciences Acquisition (BLAC), SEP Acquisition (SEPA), SurgePays (SURG), Neuronetics (STIM), and Cytosorbents (CTSO). These companies are all part of the "medical equipment" industry.
FONAR (NASDAQ:FONR) and Cutera (NASDAQ:CUTR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.
50.6% of FONAR shares are held by institutional investors. Comparatively, 90.7% of Cutera shares are held by institutional investors. 2.2% of FONAR shares are held by company insiders. Comparatively, 0.4% of Cutera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Cutera had 1 more articles in the media than FONAR. MarketBeat recorded 3 mentions for Cutera and 2 mentions for FONAR. FONAR's average media sentiment score of 0.96 beat Cutera's score of 0.43 indicating that Cutera is being referred to more favorably in the news media.
Cutera received 162 more outperform votes than FONAR when rated by MarketBeat users. However, 73.93% of users gave FONAR an outperform vote while only 64.80% of users gave Cutera an outperform vote.
Cutera has a consensus price target of $7.67, suggesting a potential upside of 404.39%. Given FONAR's higher possible upside, analysts plainly believe Cutera is more favorable than FONAR.
FONAR has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Cutera has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.
FONAR has higher earnings, but lower revenue than Cutera. Cutera is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
FONAR has a net margin of 10.66% compared to FONAR's net margin of -73.42%. Cutera's return on equity of 7.50% beat FONAR's return on equity.
Summary
FONAR beats Cutera on 9 of the 17 factors compared between the two stocks.
Get Cutera News Delivered to You Automatically
Sign up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CUTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
